Insider Transactions in Q2 2025 at Volitionrx LTD (VNRX)
Insider Transaction List (Q2 2025)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Jun 12
2025
|
Cameron John Reynolds President and CEO |
BUY
Open market or private purchase
|
Direct |
12,500
+0.53%
|
$0
$0.59 P/Share
|
|
Jun 03
2025
|
Guy Archibald Innes |
BUY
Open market or private purchase
|
Direct |
20,000
+2.2%
|
$0
$0.54 P/Share
|
|
Jun 01
2025
|
Gael Forterre Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,230
-1.9%
|
$0
$0.64 P/Share
|
|
Jun 01
2025
|
Ethel Rubin |
BUY
Grant, award, or other acquisition
|
Direct |
11,983
+20.84%
|
-
|
|
Jun 01
2025
|
Jacob Vincent Micallef Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
21,526
-5.05%
|
$0
$0.5 P/Share
|
|
Jun 01
2025
|
Ann Louise Batchelor Group Chief Marketing Officer |
BUY
Grant, award, or other acquisition
|
Direct |
18,341
+11.07%
|
-
|
|
Jun 01
2025
|
Andrew Retter Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
4,598
-3.13%
|
$0
$0.5 P/Share
|
|
Jun 01
2025
|
Andrew Retter Chief Medical Officer |
BUY
Grant, award, or other acquisition
|
Direct |
13,069
+8.18%
|
-
|
|
Jun 01
2025
|
Terig Hughes Chief Financial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
17,406
+4.1%
|
-
|
|
Jun 01
2025
|
Gael Forterre Chief Commercial Officer |
BUY
Grant, award, or other acquisition
|
Direct |
6,690
+3.88%
|
-
|
|
Jun 01
2025
|
Salvatore Thomas Butera CEO - Volition Veterinary |
SELL
Payment of exercise price or tax liability
|
Direct |
11,683
-3.58%
|
$0
$0.5 P/Share
|
|
Jun 01
2025
|
Salvatore Thomas Butera CEO - Volition Veterinary |
BUY
Grant, award, or other acquisition
|
Direct |
23,377
+6.69%
|
-
|
|
Jun 01
2025
|
Rodney Gerard Rootsaert Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
6,408
-4.34%
|
$0
$0.5 P/Share
|
|
Jun 01
2025
|
Rodney Gerard Rootsaert Secretary |
BUY
Grant, award, or other acquisition
|
Direct |
10,190
+6.45%
|
-
|
|
Jun 01
2025
|
Michel Gaetan Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
7,835
-2.02%
|
$0
$0.5 P/Share
|
|
Jun 01
2025
|
Nicholas Plummer GC - Volition Diagnostics |
BUY
Grant, award, or other acquisition
|
Direct |
16,086
+7.67%
|
-
|
|
Jun 01
2025
|
Kim Nguyen |
BUY
Grant, award, or other acquisition
|
Direct |
11,983
+10.86%
|
-
|
|
Jun 01
2025
|
Jasmine Kway CEO - Singapore Volition |
BUY
Grant, award, or other acquisition
|
Direct |
8,327
+4.18%
|
-
|
|
May 19
2025
|
Jacob Vincent Micallef Chief Scientific Officer |
BUY
Open market or private purchase
|
Direct |
50,000
+10.5%
|
$0
$0.43 P/Share
|
|
May 19
2025
|
Cameron John Reynolds President and CEO |
BUY
Open market or private purchase
|
Direct |
20,000
+0.86%
|
$0
$0.44 P/Share
|
|
May 01
2025
|
Jacob Vincent Micallef Chief Scientific Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
18,319
-4.65%
|
$0
$0.49 P/Share
|
|
May 01
2025
|
Gael Forterre Chief Commercial Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,698
-2.27%
|
$0
$0.49 P/Share
|
|
May 01
2025
|
Salvatore Thomas Butera CEO - Volition Veterinary |
SELL
Payment of exercise price or tax liability
|
Direct |
10,205
-3.26%
|
$0
$0.49 P/Share
|
|
May 01
2025
|
Rodney Gerard Rootsaert Secretary |
SELL
Payment of exercise price or tax liability
|
Direct |
5,453
-3.81%
|
$0
$0.49 P/Share
|
|
May 01
2025
|
Andrew Retter Chief Medical Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
3,913
-2.84%
|
$0
$0.49 P/Share
|
|
May 01
2025
|
Michel Gaetan Chief Operating Officer |
SELL
Payment of exercise price or tax liability
|
Direct |
6,844
-1.73%
|
$0
$0.49 P/Share
|